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OBJECTIVE: Periodic assessment of health status is criti-
cal for risk stratification and case management. This
study tested a simple telephone-based interview to assess
current asthma status (past hour) and determined the ex-
tent to which a questionnaire-based measure could pre-
dict peak expiratory flow (PEF).
METHODS: Thirty-nine adult asthma patients (56%
participation) were randomly selected from among man-
aged care patients with a medical or pharmacy claim for
asthma in the six months prior to interview. Volunteers
completed four weekly telephone interviews to assess
current asthma status. Using a portable device, two PEF
measurements were taken after each interview. The inter-
view screened for seven asthma symptoms. Using 10-
point anchored scales, volunteers also rated their abilities
to: 1) take a full and complete deep breath; 2) perform
self-defined moderately demanding activities; and 3) per-
form self-defined demanding activities, during the recall
period. Linear regression was used to model percent-pre-
dicted PEF. Covariates that contributed significantly to
improving model fit were retained. Linear and nonlinear
terms were tested. We fit the model using baseline data
and tested it on follow-up data. 
RESULTS: A linear model including the average of: 1)
the three scaled covariates (ability to take a full and com-
plete deep breath, perform moderately-demanding activi-
ties, and perform demanding activities); 2) body mass in-
dex; and 3) an interaction term, correlated well with
percent-predicted PEF (r  0.72). When applying the
model to follow-up data, the correlation coefficient re-
mained high (r  0.63). 
CONCLUSIONS: This 2-minute telephone-based inter-
view provides a rapid, simple, and accurate alternative to
more complicated and time intensive measures to assess
asthma status.
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No asthma HRQoL scale specifically for Native Ameri-
can adults currently exists. 
OBJECTIVE: To develop and validate an Asthma Qual-
ity of Life Questionnaire for Native American Adults
(AQLQ-NAA). 
METHODS: A focus group was conducted to modify the
20 item Asthma Quality of Life Questionnaire-Marks
(AQLQ-M) to render it more culturally relevant for Na-
tive Americans. The AQLQ-NAA was constructed using
transcribed focus group proceedings. Adult asthmatics at
the Albuquerque PHS Indian Hospital and affiliated field
clinics completed the AQLQ-NAA. Higher scores on the
AQLQ-NAA indicate a more severe impact on HRQoL.
Principal components analysis (PCA) was conducted to
identify domains of the AQLQ-NAA. Cronbach’s alphas
for the AQLQ-NAA and its domains were calculated.
Construct validity of the AQLQ-NAA and its domains
was determined by correlating scores with pertinent
asthma related variables for the past 6 and 12 months. 
RESULTS: The AQLQ-NAA items have emphasis on re-
strictions in social, community and cultural activities.
Forty-one respondents completed the AQLQ-NAA. PCA
identified three components with eigenvalues above 1.00.
The components were named Community and Social Re-
strictions, Symptoms and Activity Limitations and Psy-
chological Impact. Cronbach’s alphas for the total
AQLQ-NAA and its domains were 0.94, 0.92, 0.88, and
0.87, respectively. Total AQLQ-NAA and most individ-
ual domain scores correlated significantly, and in the cor-
rect direction, with urgent care visits (p  0.05), physi-
cian visits (p  0.05), and total number of asthma
medications (p  0.05). All other correlations were in ex-
pected directions. 
CONCLUSIONS: The AQLQ-NAA and its domains
showed good internal consistency and construct validity
and should provide a valuable HRQoL outcome measure
of asthma-specific medical care interventions among Na-
tive Americans.
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OBJECTIVE: The purpose of this study was to evaluate
the beneficial effects of the asthma education programs
for adults and children.
METHODS: Literature on previously published articles
on economic evaluations of asthma educational interven-
tions, impact on frequency and cost of healthcare utiliza-
tion was reviewed. Patients included in the study had
asthma that was either previously diagnosed or con-
firmed at the start of the study. After obtaining baseline
data, the patients were given asthma self-management
education programs for a duration of anywhere from 3
to 7 weeks after which they were followed up for a pe-
riod of 12 months. Both costs and benefits in this study
were defined in monetary terms. This study was done
from the payer’s perspective. The benefit of the education
program was measured by looking at the reduction in
health utilization rate and thereby calculating the cost
savings due to the intervention.
RESULTS: The clinical results revealed that the asthma
education program led to a significant decrease in the utili-
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zation of health services. The overall C/B ratio turned out
to be 1:6.52, in other words, compared to control group,
asthma education programs reduce direct medical costs by
$6.52 for each dollar spent in providing the education.
CONCLUSION: Our study shows that the asthma educa-
tion programs are beneficial in reducing the direct medical
costs associated with asthma. These findings suggest that
education programs benefit the patient and lead to their
well being which in turn will benefit both the patient and
the third-party payers.
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Treatment options for control of asthma are numerous.
However, as for other diseases, there are often differences
between clinical trials and what takes place in clinical
practice. 
OBJECTIVES: To present some methodological issues in
relation to the first “real-life” pharmacoeconomics study
(PECT) in asthma, comparing the cost-effectiveness of
budesonide Turbuhaler versus sodium cromoglycate Spin-
haler for moderately asthmatic children, aged 5–11 years. 
METHODS: One hundred thirty-eight Swedish patients
were randomized to one of the two treatments. Patients
were then treated according to local clinical practice on
an open basis for 12 months. Thus, any additional ther-
apy was allowed, including switching to the comparator.
The objective was to reach the same degree of patient
asthma control in both groups. There were six scheduled
study visits. Efficacy (asthma control) and resource use
were recorded in patient diaries and case report forms. 
RESULTS: 1) A number of problems in relation to ran-
domization, such as center effects and sample selection
bias, were experienced. 2) A dilution of difference in effect
was experienced due to the fact that 36% of patients on
sodium cromoglycate had to switch to budesonide because
of poor control of asthma (as judged by the physician). 3)
Because there was insufficient data available on which to
base a power calculation, too few patients were recruited.
4) Due to large standard deviations and the problems
listed above, a significant advantage in budesonide costs
could only be identified when various background factors
were taken into account in a multiple regression analysis. 
CONCLUSIONS: A number of different methodological
problems compared to ordinary piggy-back economic
evaluations arise in PECTs. Careful consideration of de-
sign is necessary to ensure high-quality research. Innova-
tive methodological approaches, such as multiple regres-
sion analysis, are required.
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OBJECTIVE: To evaluate the importance of accounting
for correlations between observations when analyzing re-
peated measures of healthcare utilization. 
METHODS: Poisson regression was applied with and with-
out generalized estimating equations to analyze -agonist
use, healthcare contacts, and nocturnal awakenings in
chronic asthmatics in two large similarly designed, 12-week,
randomized trials of Montelukast, a once daily leukotriene
receptor antagonist, compared to placebo. Data on -ago-
nist use and nocturnal awakenings were recorded on daily
diary cards. Healthcare contacts included visits to physi-
cians, the emergency room, and hospitalizations docu-
mented as not mandated by the protocols. 
RESULTS: Montelukast compared to placebo decreased
the rate of days of -agonist use by 9.6% (p  0.0001),
nights with awakenings by 22.5% (p  0.0001) and
healthcare contacts by 23.0% (p  0.09) when analyzed
without generalized estimating equations. Use of general-
ized estimating equations did not change the parameter
estimates for any of the health outcomes measured, but
did increase the standard errors and confidence intervals
in all cases. The increase in the standard errors ranged
from 19.1% to 355.1%. -agonist use and nights with
awakenings remained statistically significant. However,
healthcare contacts became less significant (p  0.16). 
CONCLUSION: Failure to account for correlations be-
tween observations may lead to erroneous conclusions
based on significance levels that are too small. In large
samples, exceeding 100–200 patients, generalized estimat-
ing equations provide one method of obtaining correct sig-
nificance levels and confidence intervals when data are
correlated. The example above included daily values for
12 weeks in 1300 patients. Other methods of adjusting for
correlated data are needed in smaller samples.
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OBJECTIVES: Healthcare providers need accurate infor-
mation about all aspects of healthcare delivery. Clinical
trials provide useful information concerning the clinical
efficacy of treatment, but they are not representative of
the routine conditions with which patients must contend
when following treatment regimens. Database studies are
being used increasingly to provide information about pa-
tient adherence under routine conditions. 
